buserelin has been researched along with Testicular Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bevers, MM; de Jong, FH; Dieleman, SJ; Grootenhuis, AJ; Klaij, IA; Steenbergen, J; Timmerman, MA; van Sluijs, FJ | 1 |
| Huhtaniemi, I; Orava, M; Rannikko, S; Vihko, R | 1 |
2 other study(ies) available for buserelin and Testicular Neoplasms
| Article | Year |
|---|---|
Inhibin, gonadotrophins and sex steroids in dogs with Sertoli cell tumours.
Topics: Animals; Buserelin; Dogs; Estradiol; Follicle Stimulating Hormone; Inhibins; Luteinizing Hormone; Male; Pituitary Gland; Sertoli Cell Tumor; Testicular Neoplasms; Testosterone | 1990 |
Steroid sulfates in testis tissue of prostatic cancer patients treated for six months with the gonadotropin releasing hormone agonist buserelin.
Topics: Aged; Androgens; Buserelin; Combined Modality Therapy; Humans; Male; Middle Aged; Orchiectomy; Testicular Neoplasms; Testis | 1989 |